Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2.
暂无分享,去创建一个
M. Wadhwa | C. Bird | R. Thorpe | B. Gharizadeh | H. Mellstedt | P. Ragnhammar | M. Hassan | A. Hjelm Skog | Robin Thorpe | Anna-Lena Hjelm Skog | Moustapha Hassan | Håkan Mellstedt